PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 5, 2024Frontiers in Oncology23 citationsOpen Access

Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for recurrent/metastatic head and neck cancer cases – the first study on ChatGPT 4o and a comparison to ChatGPT 4.0

View Full Paper
BSBenedikt SchmidlTHTobias HüttenSPSteffi Pigorsch

Key Points

Key points are not available for this paper at this time.

Abstract

Recurrent and metastatic head and neck squamous cell carcinoma (HNSCC) is characterized by a complex therapeutic management that needs to be discussed in multidisciplinary tumor boards (MDT). While artificial intelligence (AI) improved significantly to assist healthcare professionals in making informed treatment decisions for primary cases, an application in the even more complex recurrent/metastatic setting has not been evaluated yet. This study also represents the first evaluation of the recently published LLM ChatGPT 4o, compared to ChatGPT 4.0 for providing therapy recommendations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Schmidl et al. (2024) studied this question.

synapsesocial.com/papers/68e5932eb6db64358752ee01https://doi.org/10.3389/fonc.2024.1455413
Ask AI
Helpful
Bookmark
Share
View Full Paper